AstraZeneca moves US court against Dr Reddy’s Laboratories on generic drug Brilinta

Pharma major AstraZeneca has filed a petition in a USA court alleging Dr Reddy's Laboratories Limited is attempting to come out with a generic version of its patented blockbuster drug Brilinta (Ticagrelor) in the US market before the expiration of a patent of the drug (276)

The post AstraZeneca moves US court against Dr Reddy’s Laboratories on generic drug Brilinta appeared first on Firstpost.